Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Stotz

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2014
A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patientsJoanna Szkandera, Martin Pichler, Gudrun Absenger, et al.
Plos One|August 19, 2014
Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patientsMichael Stotz, Joanna Szkandera, Julia Seidel, et al.
American Journal of Surgery|March 4, 2014
The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patientsJoanna Szkandera, Martin Pichler, Gudrun Absenger, et al.
Oncotarget|December 10, 2017
Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line settingJakob Michael Riedl, Florian Posch, Florian Moik, et al.
Therapeutic Advances in Musculoskeletal Disease|December 21, 2020
The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective studyAngelika Lackner, Viktoria Tiefenthaler, Jalia Mirzayeva, et al.
Clinical Chemistry and Laboratory Medicine|October 12, 2018
Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancerAnna L Lembeck, Florian Posch, Eva V Klocker, et al.
Cancer Medicine|June 16, 2020
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsDominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, et al.
Wiener Klinische Wochenschrift|August 23, 2018
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysisEva Asamer, Joanna Szkandera, Paul Gibiser, et al.
Cancer Medicine|January 20, 2018
Risk stratification for febrile neutropenia in patients with testicular germ cell tumorsAngelika Terbuch, Florian Posch, Richard Partl, et al.
BMC Cancer|June 17, 2017
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort studyJakob Michael Riedl, Florian Posch, Angelika Bezan, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2014
A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patientsJoanna Szkandera, Martin Pichler, Gudrun Absenger, et al.
Plos One|August 19, 2014
Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patientsMichael Stotz, Joanna Szkandera, Julia Seidel, et al.
American Journal of Surgery|March 4, 2014
The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patientsJoanna Szkandera, Martin Pichler, Gudrun Absenger, et al.
Oncotarget|December 10, 2017
Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line settingJakob Michael Riedl, Florian Posch, Florian Moik, et al.
Therapeutic Advances in Musculoskeletal Disease|December 21, 2020
The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective studyAngelika Lackner, Viktoria Tiefenthaler, Jalia Mirzayeva, et al.
Clinical Chemistry and Laboratory Medicine|October 12, 2018
Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancerAnna L Lembeck, Florian Posch, Eva V Klocker, et al.
Cancer Medicine|June 16, 2020
External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patientsDominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, et al.
Wiener Klinische Wochenschrift|August 23, 2018
Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysisEva Asamer, Joanna Szkandera, Paul Gibiser, et al.
Cancer Medicine|January 20, 2018
Risk stratification for febrile neutropenia in patients with testicular germ cell tumorsAngelika Terbuch, Florian Posch, Richard Partl, et al.
BMC Cancer|June 17, 2017
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort studyJakob Michael Riedl, Florian Posch, Angelika Bezan, et al.
Pageof 6